Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA:688796)

Market Cap	31.19B +985.0%
Revenue (ttm)	1.19B +48.8%
Net Income	132.21M
EPS	0.33
Shares Out	n/a
PE Ratio	235.92
Forward PE	199.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,203,000
Average Volume	2,620,832
Open	76.60
Previous Close	77.51
Day's Range	76.05 - 78.98
52-Week Range	48.06 - 79.88
Beta	n/a
RSI	61.13
Earnings Date	Mar 27, 2026

About SHA:688796

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally. It operates through five segments: Gene-editing services, Pre-clinical pharmacology and efficacy evaluation, Animal models selling, Antibody development, and Innovative drugs development. The Gene-editing services segment provides the customized gene editing services based on animals as well as c...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2008
• Employees: 1,306
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688796